July 12, 2025

NEW YORK, July 12, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) between May 9, 2024 and May 8, 2025, both dates inclusive (the “Class Period”), of the important July 14, 2025 lead plaintiff deadline. SO WHAT: If you purchased Iovance securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Iovance class action, go to https://rosenlegal.com/submit-form/?case_id=39482, call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more

Bitget Launchpool to List Chainbase (C) with 2.75M in Token Rewards Bitget Launchpool to List Chainbase (C) with 2.75M in Token Rewards VICTORIA, Seychelles, July 12, 2025 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange, and Web3 company has announced the listing of Chainbase (C) in the Innovation and AI Zone, for spot trading. Besides being available for spot trading, Bitget will launch an exclusive Launchpool rewards campaign with up to 2,750,000 C up for grabs. Chainbase is an omnichain data network. Spot trading for Chainbase (C) will begin on 14 July 2025 at 12:00 (UTC) under the C/USDT trading pair.

NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GeneDx Holdings Corp. (NASDAQ: WGS) resulting from allegations that GeneDx may have issued materially misleading business information to the investing public. SO WHAT: If you purchased GeneDx securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. WHAT TO DO NEXT: To join the prospective class action, go

NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Semler Scientific, Inc. (NASDAQ: SMLR) resulting from allegations that Semler Scientific may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Semler Scientific securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. WHAT TO DO NEXT: To join the prospective class